There is a significant burden of disease associated with JPsA and ERA, with patients experiencing structural damage progression, risk of disability, and comorbidities that may persist into adulthood. This presentation led by Hermine Brunner, MD educates on the importance of early recognition and management.
RheumNow Live is Coming to Town (3.11.2022)
Long-Term Safety Profile of Secukinumab Analysis
QD Clinics - Lessons from the clinic (QD 165-169)
When Less (Drug) is More (Activity) (3.4.2022)
Fellow Case Presentations from RWCS 2022
QD Clinics - Lessons from the clinic (QD 161-164)
Delays in SpA Diagnosis (2.25.2022)
RheumNow Podcast - RWCS 2022 Roundup (2.19.2022)
QD Clinics 157-160 Lessons from the Clinic
Hand OA and Heroes in Rheumatology (2.11.2022)
An Ounce of Prevention (2.4.2022)
The Last Word on JAK Inhibitor Safety and 1133 Study (1.28.2022)
Believing is Doing (1.21.2022)
The Overpricing of Drugs (1.14.2022)
Comorbidities in axSpA- A Focus on Cardiovascular Features Sponsored by Novartis Medical Affairs
2021 Rheumatology Year in Review (1.7.2022)
Best of 2021 -Jack of All Subspecialties (12.31.2021)
My Podcast Gift (12.24.2021)
Indications Awaiting (12.17.21)
Women Leaders in Rheumatology
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive